Document Detail


Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.
MedLine Citation:
PMID:  10840013     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The blockade of angiotensin II (Ang II) formation has protective effects on cardiovascular tissue; however, the role of Ang II in atrial electrical remodeling is unknown. The purpose of this study was to investigate the effects of candesartan and captopril on atrial electrical remodeling. METHODS AND RESULTS: In 24 dogs, the atrial effective refractory period (AERP) was measured before, during, and after rapid atrial pacing. Rapid atrial pacing at 800 bpm was maintained for 180 minutes. The infusion of saline (n=8), candesartan (n=5), captopril (n=6), or Ang II (n=5) was initiated 30 minutes before rapid pacing and continued throughout the study. In the saline group, AERP was significantly shortened during rapid atrial pacing (from 149+/-11 to 132+/-16 ms, P<0.01). There was no significant difference in AERP shortening between the saline group and the Ang II group. However, in the candesartan and captopril groups, shortening of the AERP after rapid pacing was completely inhibited (from 142+/-9 to 147+/-12 ms with candesartan, from 153+/-15 to 153+/-14 ms with captopril, P=NS). Although rate adaptation of the AERP was lost in the saline group, this phenomenon was preserved in the candesartan and captopril groups. CONCLUSIONS: The inhibition of endogenous Ang II prevented AERP shortening during rapid atrial pacing. These results indicate for the first time that Ang II may be involved in the mechanism of atrial electrical remodeling and that the blockade of Ang II may lead to the better therapeutic management of human atrial fibrillation.
Authors:
H Nakashima; K Kumagai; H Urata; N Gondo; M Ideishi; K Arakawa
Related Documents :
3976903 - Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node a...
7513403 - Comparison of ventricular function in atrial rate adaptive versus dual chamber rate ada...
11355083 - Relationship between six-minute walking test and pulmonary function and ventilatory dri...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Circulation     Volume:  101     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-06-21     Completed Date:  2000-06-21     Revised Date:  2003-12-05    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2612-7     Citation Subset:  AIM; IM    
Affiliation:
Second Department of Internal Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan. kxk@fukuoka-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / antagonists & inhibitors*,  pharmacology
Animals
Antihypertensive Agents / pharmacology*
Atrial Fibrillation / drug therapy*,  physiopathology*
Atrial Function / drug effects,  physiology
Benzimidazoles / pharmacology*
Captopril / pharmacology
Dogs
Female
Heart Conduction System / drug effects,  physiopathology*
Male
Myocardium / chemistry
Pacemaker, Artificial
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Receptors, Angiotensin / physiology
Sinoatrial Node / physiology
Tetrazoles / pharmacology*
Time Factors
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Benzimidazoles; 0/Receptor, Angiotensin, Type 1; 0/Receptor, Angiotensin, Type 2; 0/Receptors, Angiotensin; 0/Tetrazoles; 11128-99-7/Angiotensin II; 139481-59-7/candesartan; 62571-86-2/Captopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of the maze operation on health-related quality of life in patients with atrial fibrillation...
Next Document:  High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c...